Litcius/Paper detail

Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial

Javed Butler, Muhammad Shahzeb Khan, Stefan D. Anker, Gregg C. Fonarow, Raymond J. Kim, Savina Nodari, Christopher M. O’Connor, Burkert Pieske, Elisabeth Pieske‐Kraigher, Hani N. Sabbah, Michele Senni, Adriaan A. Voors, James E. Udelson, Jim Carr, Mihai Gheorghiade, Gerasimos Filippatos

2020Journal of Cardiac Failure101 citationsDOIOpen Access PDF

Topics & Concepts

MedicineEjection fractionHeart failureCardiologyInternal medicineVentricular functionMitochondrial Function and PathologyCardiac electrophysiology and arrhythmiasViral Infections and Immunology Research
Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial | Litcius